Safety of and Immune Response to Two Different Dengue Virus Vaccines in Individuals Previously Immunized Against Dengue Virus

Bio2RDF uri

Safety of and Immune Response to Two Different Dengue Virus Vaccines in Individuals Previously Immunized Against Dengue Virus

Clinical Study [clinicaltrials_vocabulary:Clinical-Study]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]

http://bio2rdf.org/clinicaltrials:NCT00458120

Bio2RDF identifier

NCT00458120

http://www.w3.org/2001/XMLSchema#string

Bio2RDF namespace

clinicaltrials

http://www.w3.org/2001/XMLSchema#string

Bio2RDF uri

http://bio2rdf.org/clinicaltrials:NCT00458120

http://www.w3.org/2001/XMLSchema#string

brief summary [clinicaltrials_vocabulary:brief-summary]

Dengue fever, which is ...... a different dengue serotype.

http://www.w3.org/2001/XMLSchema#string

brief title [clinicaltrials_vocabulary:brief-title]

Safety of and Immune Response ...... Immunized Against Dengue Virus

http://www.w3.org/2001/XMLSchema#string

clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

Number, severity, and seriousness of vaccine-related adverse events observed through active and passive surveillance Throughout study [clinicaltrials_resource:42c86dcd5480f750b1c447e288bd5933]

Number, severity, and seriousness of vaccine-related adverse events observed through active and passive surveillance Throughout study [clinicaltrials_resource:9877a86a14bbc0d53ec9b2ba48c59854]

clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

Number, severity, and seriousness of vaccine-related adverse events observed through active and passive surveillance Throughout study [clinicaltrials_resource:1a14ca3a852e7bdc31abed70f0e81d17]

Number, severity, and seriousness of vaccine-related adverse events observed through active and passive surveillance Throughout study [clinicaltrials_resource:79ef0694f9147e73e9c23a6b9486d101]

Number, severity, and seriousness of vaccine-related adverse events observed through active and passive surveillance Throughout study [clinicaltrials_resource:a24e77ae00b15fa81f7156efa2a59346]

Number, severity, and seriousness of vaccine-related adverse events observed through active and passive surveillance Throughout study [clinicaltrials_resource:d736f4b9c08c03acc3e880682330b871]

Number, severity, and seriousness of vaccine-related adverse events observed through active and passive surveillance Throughout study [clinicaltrials_resource:e3d0ff95973adfb386cd4df82b392027]

collaborator [clinicaltrials_vocabulary:collaborator]

National Institute of Allergy and Infectious Diseases (NIAID) [clinicaltrials_resource:d9a74aeb9c0d0448f38e08189395de72]

completion date [clinicaltrials_vocabulary:completion-date]

2008-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

condition [clinicaltrials_vocabulary:condition]

Dengue Hemorrhagic Fever [clinicaltrials_resource:a9ebb4806415eb7ad46e821aebab45a2]

condition browse [clinicaltrials_vocabulary:condition-browse]

Severe Dengue [clinicaltrials_resource:134f41f763d8b79d8cfda9d19ff48273]

Dengue [clinicaltrials_resource:58555fc155d8a1d38d091ee174ba5563]

Hemorrhagic Fevers, Viral [clinicaltrials_resource:bd7a8493a2578119d2f6bfbd7666af37]

condition mesh [clinicaltrials_vocabulary:condition-mesh]

Severe Dengue [clinicaltrials_resource:134f41f763d8b79d8cfda9d19ff48273]

Dengue [clinicaltrials_resource:58555fc155d8a1d38d091ee174ba5563]

Hemorrhagic Fevers, Viral [clinicaltrials_resource:bd7a8493a2578119d2f6bfbd7666af37]

country [clinicaltrials_vocabulary:country]

United States [clinicaltrials_resource:f253efe302d32ab264a76e0ce65be769]

detailed description [clinicaltrials_vocabulary:detailed-description]

The World Health Organi ...... tional skin biopsy sub-study.

http://www.w3.org/2001/XMLSchema#string

download date [clinicaltrials_vocabulary:download-date]

ClinicalTrials.gov processed this data on August 10, 2015

http://www.w3.org/2001/XMLSchema#string

eligibility [clinicaltrials_vocabulary:eligibility]

eligibility for clinicaltrials:NCT00458120 [clinicaltrials_resource:78778b2591457b6678c9dcba5a9e47a4]

firstreceived date [clinicaltrials_vocabulary:firstreceived-date]

2007-04-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

has expanded access [clinicaltrials_vocabulary:has-expanded-access]

http://www.w3.org/2001/XMLSchema#string

intervention [clinicaltrials_vocabulary:intervention]

Placebo to rDEN1delta30 or rDEN2/4delta30(ME) [clinicaltrials_resource:840d64d3504723b02081f4cca43fd91e]

rDEN2/4delta30(ME) [clinicaltrials_resource:b82f9e01596e0149f129cfc7e92bfaf3]

rDEN1delta30 [clinicaltrials_resource:f36e5fb8702f3202f87b8aabf674d773]

is fda regulated [clinicaltrials_vocabulary:is-fda-regulated]

Yes

http://www.w3.org/2001/XMLSchema#string

is section 801 [clinicaltrials_vocabulary:is-section-801]

http://www.w3.org/2001/XMLSchema#string

keyword [clinicaltrials_vocabulary:keyword]

Dengue Fever

http://www.w3.org/2001/XMLSchema#string

Dengue Hemorrhagic Fever

http://www.w3.org/2001/XMLSchema#string

Dengue Vaccination

http://www.w3.org/2001/XMLSchema#string

lastchanged date [clinicaltrials_vocabulary:lastchanged-date]

2010-12-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

lead sponsor [clinicaltrials_vocabulary:lead-sponsor]

National Institute of Allergy and Infectious Diseases (NIAID) [clinicaltrials_resource:d9a74aeb9c0d0448f38e08189395de72]

location [clinicaltrials_vocabulary:location]

Center for Immunization Research [clinicaltrials_resource:4e142790dc248aa1c941c501eb0df29f]

nct id [clinicaltrials_vocabulary:nct-id]

NCT00458120

http://www.w3.org/2001/XMLSchema#string

number of arms [clinicaltrials_vocabulary:number-of-arms]

http://www.w3.org/2001/XMLSchema#integer

official title [clinicaltrials_vocabulary:official-title]

Evaluation of the Safety and I ...... n in Dengue Immune Individuals

http://www.w3.org/2001/XMLSchema#string

org study id [clinicaltrials_vocabulary:org-study-id]

CIR 227

http://www.w3.org/2001/XMLSchema#string

overall official [clinicaltrials_vocabulary:overall-official]

Anna Durbin, MD [clinicaltrials_resource:36f258c2b0d79c10bce906a9548de39a]

overall status [clinicaltrials_vocabulary:overall-status]

Completed [clinicaltrials_resource:07ca5050e697392c9ed47e6453f1453f]

oversight [clinicaltrials_vocabulary:oversight]

United States: Food and Drug Administration [clinicaltrials_resource:be4cea82cb21bbda79c939a4d720315b]

phase [clinicaltrials_vocabulary:phase]

Phase 1 [clinicaltrials_resource:ee4650e51426c7487977eeea8e7e6850]

primary completion date [clinicaltrials_vocabulary:primary-completion-date]

2008-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

reference [clinicaltrials_vocabulary:reference]

15566333 [pubmed:15566333]

15688284 [pubmed:15688284]

15937367 [pubmed:15937367]

responsible party [clinicaltrials_vocabulary:responsible-party]

Anna Durbin, MD, Center for Immunization Research, Johns Hopkins School of Public Health [clinicaltrials_resource:556a819bade20d703f99c1b145bb99d6]

secondary id [clinicaltrials_vocabulary:secondary-id]

WIRB Protocol Number 20070409

http://www.w3.org/2001/XMLSchema#string

source [clinicaltrials_vocabulary:source]

National Institute of Allergy and Infectious Diseases (NIAID) [clinicaltrials_resource:d9a74aeb9c0d0448f38e08189395de72]

start date [clinicaltrials_vocabulary:start-date]

2007-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

study design [clinicaltrials_vocabulary:study-design]

clinicaltrials:NCT00458120 study design [clinicaltrials_resource:3e522aa9cccf5327cd5d313458f8aa44]

study type [clinicaltrials_vocabulary:study-type]

Interventional [clinicaltrials_resource:843ac00ae5d0b7c7defb84fb42c2ce31]

url [clinicaltrials_vocabulary:url]

NCT00458120

verification date [clinicaltrials_vocabulary:verification-date]

2010-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

identifier

clinicaltrials:NCT00458120

http://www.w3.org/2001/XMLSchema#string

title

Safety of and Immune Response ...... Immunized Against Dengue Virus

@en

inDataset

clinicaltrials_resource:bio2rdf.dataset.clinicaltrials.R3